The executives have asked the Chancellor to pause the planned increase in the General Betting Duty on most remote betting activity to 25% "until the full impact of the RGD rise on jobs, investment, ...

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: ...

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: ...

(Alliance News) - A decision on whether to give the green light to the Jackdaw gas field in the North Sea is "imminent", Energy Secretary Miatta Fahnbulleh has said. But a decision on Rosebank, the ...

In London, the FTSE 100 index ended up 74.53 points, 0.7%, at 10,724.86. The FTSE 250 climbed 21.58 points, 0.1%, to 24,360.77, but the AIM all-share fell 3.25 points, 0.4%, to 767.91.

Latest share prices for WOS.L (WOS) including charting, last trade, news, history and share dealing online, buy and sell WOS.L shares.

(Alliance News) - The Betting and Gaming Council has asked Chancellor of the Exchequer John Healey to delay a planned tax hike on the industry, Sky News reported on Wednesday, ahead of Healey's ...

The FTSE 250 in London was up 171.70 points, 0.7%, at 24,510.89, and the AIM All-Share was up 2.51 points, 0.3%, at 773.67. The Cboe UK 100 was up 0.3% at 1,060.41, the Cboe UK 250 added 1.1% at ...

(Alliance News) - Andy Burnham has said he will seek to restore Donald Trump's support for Ukraine ahead of Volodymyr Zelensky's visit to Downing Street on Wednesday. The UK Prime Minister said he was ...

(Alliance News) - Andy Burnham and Kemi Badenoch traded blows over defence at Prime Minister's Questions, as he criticised Tory plans for an Iron Dome style air defence system. The Conservative leader ...

It has raised GBP3 million through a placing of 1.03 billion shares priced at 0.29 pence each, undertaken by Axis Capital Markets Ltd. An additional 10.3 million shares will be issued at the same ...

CelLBxHealth said the additional contract shows continued engagement with this "established pharmaceutical customer," which further demonstrates Parsortix's value in oncology research and drug ...